Welcome to the Alaska Chapter of the American College of Cardiology
Welcome to the Alaska Chapter of the American College of Cardiology
|
16th Annual Cardiovascular Update Conference February 6th and 7th from 8:00 am - 5:00 pm For details visit: Registration Page |
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings
Latest in Cardiology from ACC.org
- RACE-CARS: Do Community and EMS Interventions Improve Survival in Cardiac Arrest?A multi-faceted intervention strategy for treating adults with out-of-hospital cardiac arrest that involved enhanced community and EMS education and training did not result in a greater percentage of patients surviving to hospital discharge with a favorable neurologic outcome vs. usual care, based on findings from RACE-CARS presented at AHA 2026 and simultaneously published in NEJM.
- COAST-AF and SUPERIOR: Late-Breaking Science Focuses on AblationTwo separate late-breaking studies presented at AHA 2026 shed light on ablation-related procedures or medical treatment of patients after atrial fibrillation (AFib) ablation.
- DETECT-HF and BETTER CARE-HF Evaluate Novel HF Alert SystemsTwo presentations at AHA 2026 simultaneously published in JACC: Heart Failure evaluated two novel technologies: a voice-based heart failure (HF) monitoring system, and an EHR-embedded mineralocorticoid receptor antagonists (MRA) prescription prompt.
- OptimPacing: Left Bundle-Branch Pacing vs. Right Ventricular Pacing For Atrioventricular BlockLeft bundle-branch pacing was superior to right ventricular pacing in reducing the risk of death from any cause, heart failure (HF) hospitalization, or pacing-induced cardiomyopathy based on results from the international, multicenter OptimPacing trial, presented at AHA 2026 and simultaneously published in NEJM.
- ADHERE-ASCVD Analysis: Digital Outreach Improves Statin Refills Across Age GroupsDigital outreach through a variety of formats may improve short-term statin refill consistently across a broad age range, according to a prespecified analysis of the ADHERE-ASCVD trial presented at AHA 2026 and simultaneously published in JACC.
